Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors

Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors

Abstract Quitting smoking could potentially minimize the risk of a high neutrophil-to-lymphocyte ratio (NLR) among tobacco use-related (TUR) cancer survivors. A total of 1263 TUR cancer survivors aged 20 to 85 years old were investigated using data from the National Health and Nutritional Examinatio...

Full description

Bibliographic Details
Main Authors:	You Lu, Katherine Kwong, James Wells, Andrea Edwards, Zhong Chen, Tung-Sung Tseng, Kun Zhang
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-02-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-27624-1

Similar Items

Global effects of smoking, of quitting, and of taxing tobacco.
by: Jha, P, et al.
Published: (2014)

Breast cancer prognostication with neutrophil–lymphocyte ratio and platelet–lymphocyte ratio
by: Taha Bahgat
Published: (2017-01-01)

The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
by: Mukta Pujani, et al.
Published: (2021-10-01)

Tobacco treatment delivery in cancer patients in Europe: The importance of quitting smoking after a cancer diagnosis
by: Charis Girvalaki, et al.
Published: (2020-10-01)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
by: Huan Wang, et al.
Published: (2020-06-01)

Increased neutrophil/lymphocyte ratio in testicular cancer
by: Aytaç Şahin, et al.
Published: (2019-07-01)

The benefits of quitting smoking for people with cancer
by: Svetlana Ristic, et al.
Published: (2019-03-01)

Smoking behavior of males attending the quit tobacco clinics in Bahrain and their knowledge on tobacco smoking health hazards
by: Randah R. Hamadeh, et al.
Published: (2018-01-01)

Are neutrophil-lymphocyte and platelet-lymphocyte ratios valuable in predicting prostate cancer?
by: Ahmet Camtosun, et al.
Published: (2016-12-01)

Quit smoking experts′ opinions toward quality and results of quit smoking methods provided in tobacco cessation services centers in Iran
by: Gholamreza Heydari, et al.
Published: (2015-01-01)

Prognostic value of neutrophil‐to‐lymphocyte ratio in breast cancer
by: Jie Chen, et al.
Published: (2015-01-01)

Neutrophil-Lymphocyte Ratio in Different Stages of Breast Cancer
by: Fezzeh Elyasinia, et al.
Published: (2017-05-01)

The ratio of neutrophil to lymphocyte is a predictor in endometrial cancer
by: Dong Yangyang, et al.
Published: (2019-04-01)

Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis
by: Peng You-Fan, et al.
Published: (2015-04-01)

Quit Smoking before Orthopaedic Surgery
by: Sheung-tung Ho
Published: (2017-12-01)

Prognostic Significant of Neutrophil: Lymphocyte Ratio, Platelet – Lymphocyte ratio, and Lymphocyte – Monocyte ratio in Kurdish Patients with breast cancer
by: S. Khazaei, et al.
Published: (2022-07-01)

Correlation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and carcinoembrionic antigen level in colorectal cancer
by: Oktania Candrawati, et al.
Published: (2018-08-01)

Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis
by: Ju-Yeon Kim, et al.
Published: (2020-12-01)

Prognostic Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in the Survival of Patients with Esophageal Cancer
by: Maryam Tajik, et al.
Published: (2021-08-01)

Role of peripheral blood parameters (neutrophil-to-lymphocyte, lymphocyte-to-monocyte and neutrophil-to-monocyte ratios) in breast cancer
by: Pratibha Tripathi, et al.
Published: (2022-01-01)

Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers
by: Daniel Thompson, et al.
Published: (2021-01-01)

E-cigarette use, its impact on tobacco smoking and the intention to quit
by: Nurasyikin Mohamad Sapiee,, et al.
Published: (2019)

Quit tobacco clinics in Bahrain: smoking cessation rates and patient satisfaction
by: Randah Ribhi Hamadeh, et al.
Published: (2017-01-01)

Comment on “Prognostic significant of neutrophil: lymphocyte ratio, platelet – lymphocyte ratio, and lymphocyte: monocyte ratio in Kurdish patients with breast cancer”
by: M. Pellicciaro, et al.
Published: (2022-11-01)

Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer
by: Liuqing Ye, et al.
Published: (2023-12-01)

Tobacco Smoking Behaviors in Cancer Survivors: The Mediation Effect of Personality and Emotional Intelligence
by: Ilaria Durosini, et al.
Published: (2022-12-01)

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
by: Domen Ribnikar, et al.
Published: (2020-12-01)

Survey of Neutrophil to Lymphocyte Ratio as Prognostic Factor in Colorectal Cancer
by: Negin Farshchian, et al.
Published: (2019-10-01)

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with testicular cancer
by: J.L. Bauza Quetglas, et al.
Published: (2020-07-01)

The prognostic significance of neutrophil/lymphocyte ratio in patients with terminal cancer
by: M. Alemdar, et al.
Published: (2020-10-01)

Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 - 2014
by: Ariadna Feliu, et al.
Published: (2018-03-01)

Smoking Rationalisation, Tobacco Dependence and Intention to Quit Among Indian Adults and Adolescents
by: Pratibha Taneja, et al.
Published: (2022-01-01)

Impact of population-level tobacco control interventions on smoking quit intention in Vietnam
by: BInh Thang Tran, et al.
Published: (2019-10-01)

Elevated Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio after First Cycle of Chemotherapy and Better Survival in Esophageal Cancer Patients Receiving Concurrent Chemoradiotherapy
by: Ruo-Han Tseng, et al.
Published: (2022-11-01)

Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio
by: Soo Jin Lee, et al.
Published: (2022-02-01)

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer
by: Aiping Ma, et al.
Published: (2022-09-01)

Does the preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict morbidity after gastrectomy for gastric cancer?
by: İbrahim Mungan, et al.
Published: (2020-02-01)

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Heart Failure
by: Viroj Wiwanitkit
Published: (2016-03-01)

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion
by: Ismail Biyik, et al.
Published: (2020-06-01)

T‐cells infiltration mediates the association between neutrophil/lymphocyte ratio and survival in gastric cancer
by: Qifei He, et al.
Published: (2023-08-01)